ABBOTT INDIA
Back to Income Statement
|
ABBOTT INDIA Last 5 Year Revenue History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Sales | ₹5,349 Cr | ₹4,913 Cr | ₹4,310 Cr | ₹4,093 Cr | ₹3,679 Cr |
What is the latest Revenue of ABBOTT INDIA ?
Year | Revenue |
---|---|
Mar2023 | ₹5,349 Cr |
Mar2022 | ₹4,913 Cr |
Mar2021 | ₹4,310 Cr |
Mar2020 | ₹4,093 Cr |
Mar2019 | ₹3,679 Cr |
How is Revenue of ABBOTT INDIA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2023 | ₹5,349 Cr | 8.86 | |
Mar2022 | ₹4,913 Cr | 14.00 | |
Mar2021 | ₹4,310 Cr | 5.30 | |
Mar2020 | ₹4,093 Cr | 11.27 | |
Mar2019 | ₹3,679 Cr | - |
Compare Revenue of peers of ABBOTT INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ABBOTT INDIA | ₹55,584.7 Cr | -1.6% | 3% | 22% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
ABBOTT INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ABBOTT INDIA | -1.6% |
3% |
22% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses